Table 1 Baseline characteristics of adult participants of the Tehran Lipid and Glucose Study in phase 3
Categorical variables | Diabetic individuals | Non-diabetic individuals | Total population |
|---|---|---|---|
Number (%) | Number (%) | Number (%) | |
Sex | |||
Women | 522 (56.3) | 2690 (57,4) | 3212 (57.2) |
Men | 405 (43.7) | 1996 (42.6) | 2401 (42.8) |
Marital status | |||
Single | 47 (5.1) | 788 (16.8) | 835 (14.9) |
Married | 819 (88.3) | 3707 (79.1) | 4526 (80.7) |
Divorced | 8 (0.9) | 60 (1.3) | 68 (1.2) |
Widowed | 53 (5.7) | 129 (2.8) | 182 (3.2) |
Education | |||
High (> 12 years) | 135 (14.8) | 1034 (22.4) | 1169 (21.1) |
Moderate (6–12 years) | 478 (52.35) | 2756 (59.7) | 3234 (58.4) |
Low (< 6 years) | 300 (32.85) | 830 (18) | 1130 (20.4) |
Smoking status | |||
Never or in the past | 809 (88.8) | 4137 (89.6) | 4946 (89.5) |
Current | 102 (11.2) | 480 (10.4) | 582 (10.5) |
Exposed to second-hand smoke at home or work | |||
No | 688 (84.7) | 3357 (81.1) | 4045 (81.7) |
Yes | 124 (15.3) | 783 (18.9) | 907 (18.3) |
Physical activity | |||
Low | 331 (36.7) | 1647 (36.1) | 1978 (36.2) |
High | 570 (63.7) | 2918 (63.9) | 3488 (63.8) |
Family history of diabetes | |||
No | 351 (45.3) | 2001 (57.4) | 2352 (55.2) |
Yes | 424 (54.7) | 1484 (42.6) | 1908 (44.8) |
Use of lipid-lowering drug | |||
No | 884 (95.4) | 4584 (97.8) | 5648 (97.4) |
Yes | 43 (4.6) | 102 (2.2) | 145 (2.6) |
Use of antihypertensive drug | |||
No | 878 (94.7) | 4595 (98.1) | 5473 (97.5) |
Yes | 49 (5.3) | 91 (1.9) | 140 (2.5) |
Family history of CVD | |||
No | 457 (66.6) | 2371 (72.4) | 2828 (71.4) |
Yes | 229 (33.4) | 902 (27.6) | 1131 (28.6) |
Continuous variables | Mean ± SD | Mean ± SD | Mean ± SD |
|---|---|---|---|
Age (years) | 49.56 ± 13.58 | 40.60 ± 12.89 | 42.09 ± 13.42 |
Height (cm) | 161.35 ± 9.46 | 163.34 ± 9.53 | 163.01 ± 9.54 |
Weight (kg) | 78.13 ± 13.75 | 71.55 ± 13.19 | 72.64 ± 13.51 |
Waist (cm) | 97.71 ± 11.36 | 88.79 ± 12.22 | 90.27 ± 12.53 |
BMI (kg/m2) | 30.04 ± 4.95 | 26.80 ± 4.37 | 27.33 ± 4.63 |
Waist-hip ratio | 0.94 ± 0.083 | 0.88 ± 0.094 | 0.89 ± 0.094 |
Systolic blood pressure (mm HG) | 120.90 ± 18.24 | 110.61 ± 15.26 | 112.31 ± 16.25 |
Diastolic blood pressure (mm HG) | 77.10 ± 10.42 | 72.23 ± 9.94 | 73.04 ± 10.18 |
Fasting plasma glucose (mg/dL) | 97.80 ± 10.61 | 87.10 ± 7.47 | 88.87 ± 8.99 |
Two-hour postprandial plasma glucose (mg/dL) | 127.64 ± 33.18 | 96.42 ± 23.18 | 101.58 ± 27.65 |
High-density lipoprotein (mg/dL) | 39.69 ± 8.97 | 42.43 ± 10.43 | 41.98 ± 10.25 |
Triglyceride (mg/dL) | 185.19 ± 101.01 | 140.42 ± 82.24 | 147.82 ± 87.22 |
Low-density lipoprotein (mg/dL) | 126.33 ± 31.87 | 114.91 ± 30.88 | 116.80 ± 31.33 |
Creatinine (mg/dL) | 1.06 ± 0.17 | 1.03 ± 0.16 | 1.04 ± 0.164 |
Cholesterol (mg/dL) | 200.64 ± 39.51 | 185.72 ± 37.90 | 188.18 ± 38.56 |